One-step sheath may offer safer stone removal
April 1st 2005Honolulu--A new "one-step" percutaneous access sheath may become the next advance in the evolution of percutaneous nephrostolithotomy, according to D. Duane Baldwin, MD, associate professor of urology at the Loma Linda (CA) University Medical School. Dr. Baldwin has completed the first trials of the device, which weds the dilation balloon to the sheath, allowing the instrument to be advanced to the kidney in a single procedure.
BPH treatment device may improve sexual function
April 1st 2005Honolulu--Not only does a form of microwave thermotherapy for BPH appear to be free of sexual side effects, it may actually improve sexual function in men with the disease, investigators from the Portsmouth (VA) Naval Hospital and Eastern Virginia Medical School reported at the Kimbrough Urological Seminar here.
Urologists play important role in Iraq, commander says
April 1st 2005Honolulu--Operation Iraqi Freedom sees its share of sick and wounded soldiers. Primarily, specialists in orthopedics and general surgery are seeing an upswing in patients coming from the conflict. But you may be surprised to learn that urologic care is the third most important medical specialty needed for these soldiers.
Researchers identify key cellular process in prostate, other cancers
March 18th 2005The interaction between two cellular proteins-Skp2 and FOXO1-influences the growth of cancer cells, and the process can be chemically reversed to stop cancer tumor growth, according to an article in the Proceedings of the National Academy of Sciences (2005; 102:169-54).
Androgen deprivation temporarily reduces men's cognitive skills
March 18th 2005Men receiving androgen deprivation therapy for prostate cancer might notice a reduction in verbal fluency, visual recognition, and visual memory, according to a small trial published in the Feb. 28 online edition of Cancer.
PCPT analysis shows finasteride lengthens lives by preventing Ca
March 18th 2005If finasteride (Proscar) were prescribed prophylactically in older men, an estimated 316,760 years of life over 10 years would be saved through the prevention of prostate cancer, according to a new analysis of data from the Prostate Cancer Prevention Trial (PCPT).
NIH study to test antidepressant for interstitial cystitis
March 2nd 2005A new National Institutes of Health-funded study is recruiting adults newly diagnosed with either painful bladder syndrome or interstitial cystitis to determine if the antidepressant amitriptyline (Elavil) will reduce the pain and frequent urination associated with the conditions.
NIH study to test antidepressant for interstitial cystitis
March 2nd 2005A new National Institutes of Health-funded study is recruiting adults newly diagnosed with either painful bladder syndrome or interstitial cystitis to determine if the antidepressant amitriptyline (Elavil) will reduce the pain and frequent urination associated with the conditions.
Biomarker test may improve prostate cancer diagnosis
March 2nd 2005A test for the urinary biomarker thymosin beta15 (Tbeta15), in combination with PSA testing, can improve both the sensitivity and specificity of prostate cancer diagnosis, according to a study published in the online edition of Prostate (Jan. 21, 2005).
Quinolone is more effective than amoxicillin-clavulanate for uncomplicated UTI
March 2nd 2005The fluoroquinolone ciprofloxacin (Cipro) appears to be more effective than amoxicillin-clavulanate (Augmentin) as a treatment for acute uncomplicated urinary tract infections in women, even in those infected with susceptible strains, according to a study published in last week's JAMA (2005; 293:949-55).
Investigational immunotherapy improves survival in men with advanced PCa
March 2nd 2005APC8015 (Provenge), an investigational form of immunotherapy, significantly improves survival in men with asymptomatic, metastatic androgen-independent prostate cancer compared with patients receiving placebo, according to a study being hailed as the first to show a survival benefit with a vaccine in patients with advanced prostate cancer.
Stone-free rates improve with access sheaths
March 1st 2005Mumbai, India—Overall stone-free rates are significantly improved in patients with renal calculi who undergo ureteroscopy using a ureteral access sheath compared with those treated without access sheaths, report researchers from Duke University, Durham, NC. Stone-free rates are improved for calculi in all portions of the kidney, they said during a presentation at the World Congress on Endourology.
When and how to perform lap pyeloplasty for UPJ obstruction
March 1st 2005The ideal management strategy for correction of ureteropelvic junction (UPJ) obstruction remains undefined. Open pyeloplasty for correction of UPJ obstruction was first described by Anderson and Hynes over a century ago and remains the gold standard against which we must compare all alternative therapies.
Recurrent UTIs caused by original E coli strain
March 1st 2005Washington—A majority of recurrent urinary tract infections in women are caused by Escherichia coli bacterial persistence or reinfection with the originally infecting E coli strain, according to findings from a Danish study presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Some VUR patients can safely stop antibiotics
March 1st 2005San Francisco—Selected children with persistent vesicoureteral reflux can safely discontinue prophylactic antibiotics without a significant risk of upper tract infections or new renal scarring, according to results of a retrospective Canadian study.
Surveys reveal shift in treatment of UPJ obstruction
March 1st 2005Mumbai, India—Since the introduction of percutaneous endopyelotomy in the mid 1980s, the treatment of adult ureteropelvic junction obstruction has undergone a tremendous change. In addition, with the increasing use of laparoscopy to treat urologic diseases, various endoscopic and laparoscopic techniques now offer success rates comparable to those of the traditional open surgery while minimizing patient morbidity.